Tag: Sun Pharma

Sun Pharma & CMSH Signed Licensing Agreement for Generics in China

sun pharma
Sun Pharmaceutical Industries Ltd. announced that one of its wholly-owned subsidiaries has granted an exclusive license to a subsidiary of China Medical System Holdings Ltd. (CMS) to develop and comme...

Sun Pharma Announced Global Licensing Agreement with the CSIR-IICT

agreement
Sun Pharmaceutical Industries Ltd. announced that it has entered into a global licensing agreement with the CSIR Indian Institute of Chemical Technology, Hyderabad (CSIR-IICT), for patents related to ...

Sun Pharma Reported Q1FY20 Financial Results

sun pharma
Sun Pharmaceutical Industries Ltd. reported financials for the first quarter ending June 30th, 2019. Highlights of Q1FY20 consolidated financials: • Sales / Income from operations at Rs. 8,259 c...

Sun Pharma Filed Application for Marketing Authorization of Tildrakizumab with PMDA

sun pharma
Sun Pharmaceutical Industries Ltd. announced that one of its wholly-owned subsidiaries has filed an application for Manufacturing and Marketing Authorization of Tildrakizumab for moderate-to-severe ps...

Sun Pharma Commissioned Production Line at Biosintez

Sun Pharma (the Netherlands, owned by India’s Sun Pharmaceutical Industries Ltd.) has commissioned a production line for making solid peroral tablets with an annual capacity of 2 billion tablets at th...

Sun Pharmaceutical Announced the U.S. Launch of Ezallor Sprinkle™ Capsules

sun pharma
Sun Pharmaceutical Industries Ltd. announced the U.S. launch of Ezallor Sprinkle™ (rosuvastatin) capsules for the treatment of three types of elevated lipid disorders in people who have difficulty swa...

Sun Pharma’s Profit Falls By Half

sun pharma
Drug major Sun Pharmaceutical Industries reported a consolidated net profit of Rs 635.88 crore for the fourth quarter ended on March 31, 2019. The company had posted a net profit of Rs 1,342.50 crore ...

Sun Pharma Looking for Partner for Chinese Expansion

sun pharma
Sun Pharmaceutical Industries Ltd. is scouting for a partner in China to help it win a larger piece of the world’s second-largest drug market, where the government is on a mission to drive down health...

Sun Pharma Raise Stake in Biosintez to 96.96%

Biosintez
Sun Pharmaceutical Industries on Wednesday said it has increased stake in Russia's PJSC Biosintez to 96.96 per cent with the purchase of additional shares worth over Rs 22 crore. The company's whol...

Sun Pharma to acquire Japanese drug manufacturer

sun pharma
Sun Pharma announced it has entered into a agreement to acquire Pola Pharma, a company engaged in research and development, manufacture, sale and distribution of branded and generic products.

Indian pharmaceutical companies intend to enter the Russian market

pharma
Indian companies, including Advance Pharma, Hetero Labs, and Sun Pharma, intend to enter the Russian pharmaceutical market, said Shubham Kumar, the Consul General of India in Vladivostok.

Sun Pharma obtained FDA approval for its biologics drug

sun pharma
Sun Pharma announced that the U.S. FDA has approved its biologics drug Ilumya (Tildrakizumab) for the treatment of adults with moderate-to-severe plaque psoriasis.

Biosintez is establishing new facility to manufacture solid dosage forms

biosintez
In November 2017, Biosintez PJSC signed a contract to build new facility for manufacturing solid dosage forms

SunPharma starts building a plant in Azerbaijan

sun pharma
The ceremony of laying foundation for a plant of solid dosage forms was held in Sumqayit